The effect of smoking-related hyperhomocysteinemia on spirometric declines in chronic obstructive pulmonary disease in elderly Japanese

Archives of Gerontology and Geriatrics

Volumn 42, Issue 2, 2006, Pages 117-124

  Kai, Sachiko ^a   Nomura, Akihiro ^a   Morishima, Yuko ^a   Ishii, Yukio ^a   Sakamoto, Tohru ^a   Hegab, Ahmed E ^a   Sekizawa, Kiyohisa ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Chronic obstructive pulmonary disease; Homocysteine; Pulmonary function tests; Smoking

Indexed keywords

HOMOCYSTEINE;

ADULT; AGED; AIRFLOW; AMINO ACID BLOOD LEVEL; ARTICLE; CALCULATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DETERIORATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; HEMOCONCENTRATION; HUMAN; HYPERHOMOCYSTEINEMIA; JAPAN; MALE; OXYGEN TENSION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENESCENCE; SMOKING; SPIROMETRY;

AGED; BODY MASS INDEX; CASE-CONTROL STUDIES; FORCED EXPIRATORY VOLUME; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; OXYGEN; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; SPIROMETRY;

EID: 29144480215     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archger.2005.06.003     Document Type: Article

References (22)

1. A. Andersson, J. Ankerst, A. Lindgren, K. Larsson, and B. Hultberg Hyperhomocysteinemia and changed plasma thiol redox status in chronic obstructive pulmonary disease Clin. Chem. Lab. Med. 39 2001 229 233
2. M.A. Avila, M.V. Carretero, E.N. Rodriguez, and J.M. Mato Regulation by hypoxia of methionine adenosyltransferase activity and gene expression in rat hepatocytes Gastroenterology 114 1998 364 371
3. D.M. Bailey, B. Davies, and J. Baker Training in hypoxia: modulation of metabolic and cardiovascular risk factors in men Med. Sci. Sports Exerc. 32 2000 1058 1066
4. L.A. Bazzano, J. He, P. Muntner, S. Vupputuri, and P.K. Whelton Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States Ann. Intern. Med. 138 2003 891 897
5. M. Buysschaert, A.S. Dramais, P.E. Wallemacq, and M.P. Hermans Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy, and insulin resistance Diabetes Care 23 2000 1816 1822
6. P. Chauveau, B. Chadefaux, M. Coude, J. Aupetit, T. Hannedouche, P. Kamoun, and P. Jungers Increased plasma homocysteine concentration in patients with chronic renal failure Miner. Electrolyte Metab. 18 1992 196 198
7. C. Fletcher, and R. Peto The natural history of chronic airflow obstruction Br. Med. J. 1 1977 1645 1648
8. M. Linden, J.B. Rasmussen, E. Piitulainen, A. Tunek, M. Larson, H. Tegner, P. Venge, L.A. Laitinen, and R. Brattsand Airway inflammation in smokers with nonobstructive and obstructive chronic bronchitis Am. Rev. Respir. Dis. 148 1993 1226 1232
9. NHLBI/WHO Workshop Report, 2001. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NIH NHLBI Publication no. 01-2701.
10. O. Nygard, S.E. Vollset, H. Refsum, I. Stensvold, A. Tverdal, J.E. Nordrehaug, M. Ueland, and G. Kvale Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study JAMA 274 1995 1526 1533
11. O. Nygard, J.E. Nordrehaug, H. Refsum, P.M. Ueland, M. Farstad, and S.E. Vollset Plasma homocysteine levels and mortality in patients with coronary artery disease N. Engl. J. Med. 337 1997 230 236
12. O. Nygard, H. Refsum, P.M. Ueland, and S.E. Vollset Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study Am. J. Clin. Nutr. 67 1998 263 270
13. P. O'Callaghan, R. Meleady, T. Fitzgerald, I. Graham the European COMAC group Smoking and plasma homocysteine Eur. Heart J. 23 2002 1580 1586
14. C.M. Pfeiffer, D.L. Huff, and E.W. Gunter Rapid and accurate HPLC assay for plasma total homocysteine and cysteine in a clinical laboratory setting Clin. Chem. 45 1999 290 292
15. Pulmonary Physiological Committee, 1993. The clinical standard of parameters in pulmonary function test. J. Jpn. Respir. Soc. 31, appendix.
16. M. Saetta, G. Turato, P. Maestrelli, C.E. Mapp, and L.M. Fabbri Cellular and structural bases of chronic obstructive pulmonary disease Am. J. Respir. Crit. Care Med. 163 2001 1304 1309
17. G. Schnyder, M. Roffi, R. Pin, Y. Flammer, H. Lange, F.R. Eberli, B. Meier, Z.G. Turi, and O.M. Hess Decreased rate of coronary restenosis after lowering of plasma homocysteine levels N. Engl. J. Med. 345 2001 1593 1600
18. G. Schnyder, M. Roffi, Y. Flammer, R. Pin, and O.M. Hess Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial JAMA 288 2002 973 979
19. J. Selhub, P.F. Jacques, P.W. Wilson, D. Rush, and I.H. Rosenberg Vitamin status and intake as primary determinants of homocysteinemia in an elderly population JAMA 270 1993 2693 2698
20. G.L. Snider Chronic obstructive pulmonary disease: risk factors, pathophysiology and pathogenesis Annu. Rev. Med. 40 1989 411 429
21. G.N. Welch, and J. Loscalzo Homocysteine and atherothrombosis N. Engl. J. Med. 338 1998 1042 1050
22. Yasuda, K., Endo, N., 1995. [Vitamin B6 (pyridoxine)] Nippon Rinsho 53 Su Pt 1, 701-703.